In a patient with an elevated white blood cell count of 17 ×10⁹/L who is allergic to trimethoprim‑sulfamethoxazole (Bactrim), what empiric antibiotic regimen can be started while awaiting urine culture results and chest X‑ray?

Empiric Antibiotic for WBC 17 with Bactrim Allergy

Start a fluoroquinolone (levofloxacin 750 mg daily or ciprofloxacin 500-750 mg twice daily) immediately while awaiting culture results, as this covers both urinary and respiratory sources in a patient with leukocytosis who cannot receive trimethoprim-sulfamethoxazole. 1, 2

Clinical Reasoning

With a WBC of 17 × 10⁹/L, you're dealing with a likely bacterial infection requiring empiric coverage. The two most common sources you're evaluating (urinary tract and respiratory) both have guideline-supported fluoroquinolone options for patients with sulfa allergies.

For Suspected UTI/Pyelonephritis:

• Fluoroquinolones are first-line alternatives when TMP-SMX cannot be used 1, 2
• Levofloxacin 750 mg daily for 5 days or ciprofloxacin 400 mg IV twice daily are appropriate empiric choices 1
• These agents achieve excellent urinary and tissue concentrations 2
• If the patient is hemodynamically stable and can tolerate oral therapy, oral fluoroquinolones are acceptable 1

For Suspected Pneumonia:

• Respiratory fluoroquinolones (levofloxacin, moxifloxacin) provide excellent coverage for community-acquired pneumonia 3, 4
• For hospitalized patients with moderate-severity pneumonia, a respiratory fluoroquinolone alone is an acceptable empiric regimen 4
• If severe pneumonia is suspected, add a beta-lactam (ceftriaxone 1-2g daily or cefotaxime 2g three times daily) to the fluoroquinolone 3, 4

Alternative Options if Fluoroquinolone Resistance is High:

For UTI:

• Ceftriaxone 1-2g IV daily or cefepime 1-2g twice daily 1
• Gentamicin 5 mg/kg daily or amikacin 15 mg/kg daily (single daily dosing) 1
• Piperacillin-tazobactam 3.375-4.5g three times daily 1

For Pneumonia:

• Ceftriaxone 1-2g daily PLUS azithromycin 500mg daily (or clarithromycin 500mg twice daily) 3, 4
• This combination covers typical and atypical pathogens without using sulfa drugs 3

Critical Pitfalls to Avoid:

1. Don't use amoxicillin or ampicillin empirically - resistance rates are too high for reliable empiric coverage 2, 5

2. Avoid cephalexin for serious infections - it lacks sufficient gram-negative coverage for pyelonephritis or pneumonia 1, 2

3. Don't use nitrofurantoin if pyelonephritis is suspected - it doesn't achieve adequate tissue levels outside the bladder 2, 5

4. If the patient has true penicillin anaphylaxis history, avoid all beta-lactams including cephalosporins and carbapenems. In this case, use ciprofloxacin PLUS clindamycin, or aztreonam PLUS vancomycin 6

Severity-Based Approach:

Mild-moderate illness (stable vitals, no hypotension):

• Oral levofloxacin 750 mg daily 1, 2

Moderate-severe illness (requiring hospitalization):

• IV levofloxacin 750 mg daily OR
• IV ciprofloxacin 400 mg twice daily 1

Severe illness (ICU-level, hypotension, high fever):

• IV ceftriaxone 2g daily PLUS azithromycin 500mg daily OR
• IV levofloxacin 750 mg daily PLUS ceftriaxone 2g daily 3, 4

Duration Planning:

• UTI/pyelonephritis: 5-7 days for uncomplicated, 10-14 days if complicated 1, 2
• Pneumonia: 5-7 days for uncomplicated CAP, extend to 10-14 days based on clinical response 3, 4
• De-escalate once cultures return - narrow to the most specific agent based on susceptibilities 1, 2

The key is starting broad coverage NOW that avoids sulfa drugs, then tailoring therapy once your urine culture and chest X-ray results are available.